204
Views
3
CrossRef citations to date
0
Altmetric
Articles

Control of bacterial soft rot disease of potato caused by Pectobacterium carotovorum subsp. carotovorum using different nanoparticles

, , ORCID Icon &
Pages 1638-1660 | Received 20 Jan 2022, Accepted 04 Aug 2022, Published online: 12 Aug 2022
 

Abstract

The aim of the study was to control potato soft rot bacterium, Pectobacterium carotovorum subsp. carotovorum using three different synthetic nanoparticles “silver, chromium III oxide and zinc oxide” within two levels in vitro and in vivo. All three nanoparticles exhibited considerable inhibitory activities more than chloramphenicol as antibiotic. Silver NPs was the most effective within highest inhibition zone at the lowest MIC (10.75mm/50 ppm) followed by chromium III oxide NPs and zinc oxide NPs (10.28 mm/100 ppm and 10.08 mm/150 ppm), respectively. Meanwhile, chloramphenicol was categorized on the last (9.34 mm/150 ppm). In vivo, controlled bacterial soft rot disease of potato was performed with Ag NPs, Cr2O3 NPs and ZnO NPs within MBC (1800, 2200 and 2600 ppm, respectively) in storage and greenhouse experiments.

Compliance with ethical standards: Ethical responsibility

Our manuscript is original research and it is not submitted to full or in parts to other journal for publication.

Disclosure statement

No potential conflict of interest was reported by the authors.

Human and animal studies

The research did not involve any studies with human participants or animal as experimental model.

Informed consent

All authors have reviewed the manuscript and approved the final version of manuscript before submission.

Authors’ contributions

Attiya H. Mohamedin and Kamal A. M. Abo-Elyousr suggested the idea of the work. Waleed A. Abdelghany and Mohamed A. M. Hussein contributed to data curation and their validation as well as writing original draft. Waleed A. Abdelghany contributed to the formal analysis of the data all authors contributed to the reviewing and editing the manuscript. All authors reviewed and approved the final version of the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.